Healthcare - Medical - Devices - NASDAQ - US
$ 11.24
0.988 %
$ 912 M
Market Cap
-18.43
P/E
CASH FLOW STATEMENT
15.3 M
OPERATING CASH FLOW
15.8 M
INVESTING CASH FLOW
-26.7 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Bioventus Inc.
| Net Income | -96.7 M |
| Depreciation & Amortization | 57.4 M |
| Capital Expenditures | -7.36 M |
| Stock-Based Compensation | 2.72 M |
| Change in Working Capital | -3.18 M |
| Others | 44.3 M |
| Free Cash Flow | 7.98 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||
| Net Income | (96.7) | (213.4) | 9.6 | 14.7 | 8.1 | 4.4 | (34.1) | (12.9) | (22.4) |
| Depreciation & Amortization | 57.4 | 66.8 | 34.9 | 28.6 | 30.3 | 29.2 | 33.1 | 28.8 | 24.5 |
| Deferred Income Tax | (2.4) | (52.8) | (9.8) | (0.5) | (0.3) | 79 K | (0.4) | (0.7) | (0.5) |
| Stock Based Compensation | 2.7 | 17.6 | 19.8 | 10.1 | 10.8 | 14.3 | 3.3 | 2.4 | 0.6 |
| Other Operating Activities | 57.6 | 182.8 | 6.1 | 3.5 | 5.4 | (5.6) | 20.4 | 6.3 | 11.9 |
| Change in Working Capital | (3.2) | (14.5) | (13.3) | 15.3 | (13.6) | 2.9 | (10.6) | (12.0) | (16.4) |
| Cash From Operations | 15.3 | (13.5) | 23.0 | 71.8 | 40.7 | 45.2 | 18.9 | 15.1 | 2.7 |
| INVESTING CASH FLOW | |||||||||
| Capital Expenditures | (7.4) | (11.5) | (7.4) | (20.7) | (8.3) | (6.1) | (7.4) | (20.8) | (6.4) |
| Other Items | 23.2 | (104.9) | (276.4) | 0.2 | 0.4 | 40 K | (52.7) | (10.5) | (4.6) |
| Cash From Investing Activities | 15.8 | (116.4) | (283.8) | (20.5) | (7.9) | (6.1) | (60.2) | (31.4) | (11.0) |
| FINANCING CASH FLOW | |||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (23.3) | 59.6 | 166.2 | (10.0) | (1.4) | (5.2) | (17.7) | (4.2) | 9.3 |
| Dividends Paid | 0 | 0 | (0.4) | (19.9) | (9.1) | (7.8) | (1.0) | (2.4) | (2.5) |
| Other Financing Activities | (4.2) | (3.4) | (1.9) | 0.3 | (0.4) | (0.2) | 50.0 | 0 | 0 |
| Cash From Financing Activities | (26.7) | 62.1 | 273.4 | (29.6) | (11.0) | (13.3) | 31.2 | (6.6) | 6.8 |
| CHANGE IN CASH | |||||||||
| Net Change In Cash | 5.1 | (67.4) | 12.4 | 22.3 | 21.7 | 25.7 | (10.8) | (24.3) | (2.0) |
| FREE CASH FLOW | |||||||||
| Free Cash Flow | 8.0 | (25.1) | 15.6 | 51.1 | 32.4 | 39.1 | 11.5 | (5.7) | (3.6) |